Eloxx Pharmaceuticals Inc (ELOX)
OTHER OTC:ELOX
Holding ELOX?
Track your performance easily

Eloxx Pharmaceuticals (ELOX) Financial Statements

286 Followers

Eloxx Pharmaceuticals Financial Overview

Eloxx Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-9.062; its P/E ratio is -0.08; Eloxx Pharmaceuticals is scheduled to report earnings on November 7, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -3.36M$ -4.11M$ -5.75M$ -6.90M$ -7.02M
EBITDA$ -3.17M$ -3.93M$ -5.56M$ -6.58M$ -6.69M
Net Income Common Stockholders$ -3.59M$ -4.34M$ -6.23M$ -6.32M$ -7.51M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 4.78M$ 4.33M$ 4.90M$ 19.46M$ 24.55M
Total Assets$ 6.04M$ 5.99M$ 7.20M$ 20.95M$ 26.88M
Total Debt$ 5.76M$ 6.11M$ 6.24M$ 13.38M$ 13.41M
Net Debt$ 983.00K$ 1.77M$ 1.33M$ -6.08M$ -11.14M
Total Liabilities$ 26.09M$ 24.59M$ 23.49M$ 31.78M$ 31.86M
Stockholders Equity$ -20.05M$ -18.60M$ -16.29M$ -10.67M$ -4.98M
Cash Flow-
Free Cash Flow$ -3.45M$ -2.07M$ -6.81M$ -5.66M$ -6.99M
Operating Cash Flow$ -3.45M$ -2.07M$ -6.81M$ -5.66M$ -6.95M
Investing Cash Flow$ 233.00K$ 14.00K$ 11.00K-$ -48.00K
Financing Cash Flow$ 3.67M$ 1.43M$ -7.50M$ 312.00K$ 1.50M
Currency in USD

Eloxx Pharmaceuticals Earnings and Revenue History

Eloxx Pharmaceuticals Debt to Assets

Eloxx Pharmaceuticals Cash Flow

Eloxx Pharmaceuticals Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis